Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide
Go back to Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide| REPROS THERAPEUTICS (NASDAQ: RPRX) | Delayed: 56.21 -0.55 (0.97%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $56.76 | 52 Week High | $3.48 | |||
| Open | $56.57 | 52 Week Low | $0.80 | |||
| Day High | $56.71 | P/E | N/A | |||
| Day Low | $55.13 | EPS | $-1.54 | |||
| Volume | 2,546,575 | |||||
| (NASDAQ: ZEAL) | Delayed: 17.59 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.59 | 52 Week High | $ | |||
| Open | $1.35 | 52 Week Low | $ | |||
| Day High | $17.59 | P/E | N/A | |||
| Day Low | $17.59 | EPS | $ | |||
| Volume | 15,962 | |||||
| (NASDAQ: ZEAL) | Delayed: 17.59 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.59 | 52 Week High | $ | |||
| Open | $1.35 | 52 Week Low | $ | |||
| Day High | $17.59 | P/E | N/A | |||
| Day Low | $17.59 | EPS | $ | |||
| Volume | 15,962 | |||||



